- Home
- QSI vs NVCT Comparison
QSI vs NVCT Comparison
Compare QSI & NVCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- QSI
- NVCT
- Stock Information
- Founded
- QSI 2013
- NVCT 2020
- Country
- QSI United States
- NVCT United States
- Employees
- QSI N/A
- NVCT N/A
- Industry
- QSI Biotechnology: Pharmaceutical Preparations
- NVCT Medicinal Chemicals and Botanical Products
- Sector
- QSI Health Care
- NVCT Health Care
- Exchange
- QSI Nasdaq
- NVCT Nasdaq
- Market Cap
- QSI 219.8M
- NVCT 249.1M
- IPO Year
- QSI N/A
- NVCT 2022
- Fundamental
- Price
- QSI $1.68
- NVCT $9.41
- Analyst Decision
- QSI Strong Buy
- NVCT Strong Buy
- Analyst Count
- QSI 3
- NVCT 3
- Target Price
- QSI $2.38
- NVCT $17.00
- AVG Volume (30 Days)
- QSI 11.2M
- NVCT 132.1K
- Earning Date
- QSI 05-15-2025
- NVCT 05-06-2025
- Dividend Yield
- QSI N/A
- NVCT N/A
- EPS Growth
- QSI N/A
- NVCT N/A
- EPS
- QSI N/A
- NVCT N/A
- Revenue
- QSI $3,443,000.00
- NVCT N/A
- Revenue This Year
- QSI $151.18
- NVCT N/A
- Revenue Next Year
- QSI $172.07
- NVCT N/A
- P/E Ratio
- QSI N/A
- NVCT N/A
- Revenue Growth
- QSI 167.94
- NVCT N/A
- 52 Week Low
- QSI $0.61
- NVCT $4.44
- 52 Week High
- QSI $5.77
- NVCT $11.80
- Technical
- Relative Strength Index (RSI)
- QSI 56.91
- NVCT 48.71
- Support Level
- QSI $1.45
- NVCT $9.92
- Resistance Level
- QSI $2.15
- NVCT $11.15
- Average True Range (ATR)
- QSI 0.20
- NVCT 0.66
- MACD
- QSI 0.02
- NVCT -0.05
- Stochastic Oscillator
- QSI 43.71
- NVCT 45.79
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.
About NVCT Nuvectis Pharma Inc.
Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.